Pemetrexed-Carboplatin and Gemcitabine-Vinorelbine in Advanced Breast Cancer
Clinical trial NCT00325234 · COMPLETED
Trial details
- NCT number
- NCT00325234
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-01
- Primary completion
- 2010-04-01
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.